Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO In 1958, in a Letter to the…
More Articles
Historical Tidbit: Jan Wolff (b. April 25, 1925) and Israel L. Chaikoff (b. July 2, 1902)—the Wolff-Chaikoff Effect Submitted by Alan D. Rogol, M.D., Ph.D. Wolff and Chaikoff discovered that…
Adriana Rodríguez González, MD I am currently a 3rd year Pediatric Endocrinology Fellow at UPMC Children’s Hospital in Pittsburgh, PA. I received my undergraduate degree at the University of Puerto Rico…
Dear PES members and friends, Midsummer greetings to all – these quieter days are flying by, as they tend to do, so hopefully you are getting some relaxation and sunshine,…
Brief Therapeutic Update from PES Drugs and Therapeutics Committee iLet ® Bionic Pancreas On May 19, 2023, the U.S. Food and Drug Administration approved the Beta Bionics iLet ACE…
Brief Therapeutic Update from PES Drugs and Therapeutics Committee Sogroya® (somapactian) Once weekly Sogroya® (somapacitan-beco, Novo Nordisk) was approved by the United States Food and Drug Administration (FDA) for treatment…
Jessika Weber, DO My name is Jessika, and I am a current 2nd year Pediatric Endocrinology Fellow at the University of Utah in Salt Lake City, UT. I received my…
Brief Therapeutic Update from PES Drugs and Therapeutics Committee The MiniMed™780G System The MiniMed 780G System from Medtronic was approved by the US Food and Drug Administration on April 21,…
Historical Tidbit: Hakaru Hashimoto, M.D. (May 4, 1881 to January 9, 1934) and Hashimoto’s Disease Submitted by: Alan D. Rogol, MD, Ph.D. Hakaru Hashimoto was a Japanese doctor and medical…
Dear PES members and friends, I am still relishing the very successful, first fully independent in-person meeting of the society in San Diego. The great success of this initial meeting…
Novo Nordisk announced that due to significant demands, they are only able to supply limited quantities of 0.25 mg, 0.5 mg, and 1 mg dose strengths of Wegovy to wholesalers…